Revenue
2018
2019
2020
2021
2022
2023
2024
2025
BeOne Medicines Ltd. (ONC)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.34B | $3.81B | $2.46B | $1.42B | $1.18B | $308.9M | $428.2M | $198.2M | $238.4M | $1.1M | $8.8M | $13.0M |
| Gross profit | $4.67B | $3.22B | $2.08B | $1.13B | $1.01B | — | — | — | — | — | — | — |
| Research & development | $2.15B | $1.95B | $1.78B | $1.64B | $1.46B | $1.29B | $927.3M | $679.0M | $269.0M | $98.0M | $58.3M | $21.9M |
| Operating income | $447.1M | −$568.2M | −$1.21B | −$1.79B | −$1.44B | −$1.66B | −$959.9M | −$705.8M | −$98.5M | −$117.1M | −$56.7M | −$15.8M |
| EBITDAderived | $588.8M | −$396.4M | −$1.12B | −$1.72B | −$1.39B | −$1.63B | −$941.3M | −$695.4M | −$93.7M | −$115.2M | −$55.2M | — |
| Net income | $286.9M | −$644.8M | −$881.7M | −$2.00B | −$1.46B | −$1.62B | −$948.6M | −$673.8M | −$93.1M | −$119.2M | −$57.1M | −$18.3M |
| Basic EPSper diluted share | $0.20 | -$0.47 | -$0.65 | -$1.49 | -$1.21 | -$1.50 | -$1.22 | -$0.93 | -$0.17 | -$0.30 | -$0.52 | -$0.18 |
| Diluted EPSper diluted share | $0.19 | -$0.47 | -$0.65 | -$1.49 | -$1.21 | -$1.50 | -$1.22 | -$0.93 | -$0.17 | -$0.30 | -$0.52 | -$0.18 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 23, 2026Form 4 | Wang LaiPresident, Global Head of R&D | SellAmerican Depositary Shares | 1.1K | $276.74 | $295.6K | 0 |
| Jun 23, 2026Form 4 | Wu XiaobinPresident and COO | SellAmerican Depositary Shares | 1.3K | $276.26 | $356.9K | 0 |
| Jun 23, 2026Form 4 | OYLER JOHNChief Executive Officer | SellAmerican Depositary Shares | 320 | $275.10 | $88.0K | 0 |
| Jun 23, 2026Form 4 | OYLER JOHNChief Executive Officer | SellAmerican Depositary Shares | 1.3K | $274.12 | $353.6K | 320 |
| Jun 23, 2026Form 4 | OYLER JOHNChief Executive Officer | SellAmerican Depositary Shares | 1.8K | $273.30 | $491.9K | 1.6K |